Pulmonary Artery Pressure as a Treatment Target to Improve the Prognosis of Idiopathic Pulmonary Arterial Hypertension　― Insight From a Cohort From Two Japanese Pulmonary Hypertension Centers ―

Background: The prognosis of pulmonary arterial hypertension (PAH) has been improving since the introduction of epoprostenol (EPO). The 3-year survival of naïve idiopathic PAH (IPAH) and hereditary PAH (HPAH) was 96% in a recent prospective Japanese registry. This increase in survival in Japan may h...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Circ Rep
Egile Nagusiak: Ishiguro, Midori, Takeuchi, Kaori, Kikuchi, Hanako, Goda, Ayumi, Inami, Takumi, Tamura, Yuichi, Kataoka, Masaharu, Fukuda, Keiichi, Satoh, Toru
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The Japanese Circulation Society 2020
Gaiak:
Original article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7921359/
https://ncbi.nlm.nih.gov/pubmed/33693237
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1253/circrep.CR-20-0006
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak